About MBQ Pharma
MBQ Pharma is a private company based in San Juan, Puerto Rico. It has reported $4,228,038 raised in five offerings on Form D since August 2026. Its chief executive is Jose Rodriguez-Orengo.
Funding Rounds (SEC Form D)
| First sale | Filed with SEC | Amount sold | Investors | Avg. check | Terms | Filing |
|---|---|---|---|---|---|---|
| May 15, 2026 | Aug 14, 2026 | $991,038target not set | 8 | $123K | EquityRule 506(b) | Form D ↗ |
| Aug 24, 2023 | Aug 14, 2026 | $500,000fully sold | 2 | $250K | DebtRule 506(b) | Form D ↗ |
| Mar 30, 2022 | Aug 14, 2026 | $325,000fully sold | 3 | $108K | DebtRule 506(b) | Form D ↗ |
| Feb 1, 2021 | Aug 14, 2026 | $882,000fully sold | 3 | $294K | EquityRule 506(b) | Form D ↗ |
| Jun 30, 2018 | Aug 14, 2026 | $1,530,000target not set | 8 | $191K | EquityRule 506(b) | Form D ↗ |
| Total, five offerings | $4,228,038 | |||||
First sale is the date the first investor in the offering committed to invest. Companies must file Form D within 15 days of that date, so filing dates run later.
Leadership Team
Executive officers and directors listed on MBQ Pharma's Form D filed Aug 14, 2026.
Earlier filings also listed Humberto Guzman (director, last listed Aug 2026), Federico Goodsaid (director, last listed Aug 2026), Eliud Hernandez (chief operating officer, last listed Aug 2026) and Cornelis Vlaar (director, last listed Aug 2026).
Sources
- SECMBQ PHARMA INC. filing history
- CompanyPrivacy policy
- CompanyContact
- CompanyMBQ-167 clinical trial announcement
- CompanyTeam